Addus HomeCare (ADUS) RBC Capital Markets Global Healthcare Conference 2026 summary
Event summary combining transcript, slides, and related documents.
RBC Capital Markets Global Healthcare Conference 2026 summary
24 May, 2026Regulatory and compliance environment
Recent moratorium on new Home Health licensure does not impact PCS operations or acquisition strategy.
Compliance investments and robust internal controls position the company favorably with payers and regulators.
Ongoing collaboration with government and industry groups to address fraud and abuse is seen as beneficial.
No significant expected impact on valuations or business operations from current regulatory actions.
Operational and growth trends
PCS census growth continues in Illinois, Texas, and New Mexico, with starts of care exceeding discharges.
Same-store billable hours per business day remain in the 2%-2.5% range, with potential to reach higher levels if rate support improves.
Caregiver app rollout in major states has improved fill rates, with Texas expected to see gains similar to Illinois.
Bridge Programs are driving 20%-30% of hospice admissions from Home Health in key markets.
M&A and market expansion
Indiana acquisitions provide a new foothold, with nearly $20 million in revenue and further expansion opportunities.
Company is well-positioned for large PCS-driven acquisitions, with a clean balance sheet and capacity for all-cash deals.
Valuations for potential deals are trending below double digits, reflecting current market multiples.
Latest events from Addus HomeCare
- Q1 2026 revenue up 7.7%, net income up 18.1%, driven by personal care and hospice growth.ADUS
Q1 202619 May 2026 - Census and hours growth accelerate with tech adoption, supporting balanced expansion and M&A.ADUS
Bank of America Global Healthcare Conference 202613 May 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with strong governance focus.ADUS
Proxy filing23 Apr 2026 - Achieved $1.4B revenue in 2025 with strong growth, stable margins, and expanding national footprint.ADUS
Investor presentation23 Apr 2026 - Hospice recovery, census growth, and tech-driven hiring fuel expansion amid stable rates.ADUS
2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026 - Strong Q4 exit, tech-driven efficiency, and robust growth outlook amid regulatory changes.ADUS
Oppenheimer 36th Annual Healthcare MedTech & Services Conference16 Mar 2026 - Margins, growth, and M&A drive performance as census rebounds and tech boosts fill rates.ADUS
47th Annual Raymond James Institutional Investor Conference3 Mar 2026 - Q4 2025 revenue and EBITDA surged, led by personal care and hospice growth.ADUS
Q4 202524 Feb 2026 - Growth driven by acquisitions, tech, and value-based care, with census recovery expected by 2026.ADUS
Jefferies 2025 Healthcare Services Conference3 Feb 2026